Sphingosine-1-phosphate receptor subtype 1 activation in the central nervous system contributes to morphine withdrawal in rodents

Opioid therapies for chronic pain are undermined by many adverse side effects that reduce their efficacy and lead to dependence, abuse, reduced quality of life, and even death. We have recently reported that sphingosine-1-phosphate (S1P) 1 receptor (S1PR1) antagonists block the development of morphi...

Descripción completa

Detalles Bibliográficos
Autores principales: Doyle, Timothy M., Hutchinson, Mark R., Braden, Kathryn, Janes, Kali, Staikopoulos, Vicky, Chen, Zhoumou, Neumann, William L., Spiegel, Sarah, Salvemini, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584082/
https://www.ncbi.nlm.nih.gov/pubmed/33092620
http://dx.doi.org/10.1186/s12974-020-01975-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584082/
https://www.ncbi.nlm.nih.gov/pubmed/33092620
http://dx.doi.org/10.1186/s12974-020-01975-2

Ejemplares similares